Tudor Investment Corp’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.46M | Buy |
+25,499
| New | +$8.38M | 0.01% | 921 |
|
|
2025
Q4 | – | Sell |
-77,687
| Closed | -$26.3M | – | 3622 |
|
|
2025
Q3 | $25.1M | Buy |
+77,687
| New | +$24.2M | 0.04% | 351 |
|
|
2025
Q1 | – | Sell |
-37,049
| Closed | -$14.9M | – | 3225 |
|
|
2024
Q4 | $13.7M | Sell |
37,049
-4,129
| -10% | -$1.73M | 0.05% | 247 |
|
|
2024
Q3 | $21.4M | Buy |
+41,178
| New | +$22M | 0.08% | 162 |
|
|
2023
Q4 | – | Sell |
-2,994
| Closed | -$1.38M | – | 2486 |
|
|
2023
Q3 | $1.3M | Sell |
2,994
-12,376
| -81% | -$5.61M | 0.01% | 1160 |
|
|
2023
Q2 | $6.83M | Buy |
15,370
+11,368
| +284% | +$5.24M | 0.08% | 305 |
|
|
2023
Q1 | $1.84M | Buy |
+4,002
| New | +$1.9M | 0.03% | 836 |
|
|
2022
Q4 | – | Sell |
-41,368
| Closed | -$18.8M | – | 2501 |
|
|
2022
Q3 | $18.8M | Buy |
41,368
+13,515
| +49% | +$6.47M | 0.41% | 19 |
|
|
2022
Q2 | $13.4M | Buy |
27,853
+24,356
| +696% | +$12M | 0.35% | 23 |
|
|
2022
Q1 | $1.72M | Buy |
+3,497
| New | +$1.6M | 0.04% | 635 |
|
|
2021
Q4 | – | Sell |
-3,268
| Closed | -$1.37M | – | 2567 |
|
|
2021
Q3 | $1.22M | Sell |
3,268
-7,584
| -70% | -$2.88M | 0.02% | 1025 |
|
|
2021
Q2 | $4.14M | Buy |
+10,852
| New | +$4.15M | 0.08% | 288 |
|
|
2021
Q1 | – | Sell |
-6,586
| Closed | -$2.12M | – | 1633 |
|
|
2020
Q4 | $2.12M | Sell |
6,586
-6,109
| -48% | -$1.87M | 0.06% | 403 |
|
|
2020
Q3 | $3.41M | Sell |
12,695
-1,878
| -13% | -$505K | 0.15% | 138 |
|
|
2020
Q2 | $3.83M | Buy |
14,573
+5,659
| +63% | +$1.51M | 0.19% | 88 |
|
|
2020
Q1 | $2.02M | Sell |
8,914
-5,010
| -36% | -$1.37M | 0.18% | 100 |
|
|
2019
Q4 | $4.21M | Sell |
13,924
-32,844
| -70% | -$9.04M | 0.19% | 108 |
|
|
2019
Q3 | $11.2M | Buy |
+46,768
| New | +$12.8M | 0.39% | 33 |
|
|
2019
Q2 | – | Sell |
-9,151
| Closed | -$2.63M | – | 1158 |
|
|
2019
Q1 | $2.63M | Buy |
+9,151
| New | +$2.65M | 0.11% | 204 |
|
|
2018
Q1 | – | Sell |
-11,904
| Closed | -$2.68M | – | 1051 |
|
|
2017
Q4 | $2.68M | Buy |
11,904
+767
| +7% | +$163K | 0.07% | 99 |
|
|
2017
Q3 | $2.12M | Sell |
11,137
-1,261
| -10% | -$240K | 0.05% | 202 |
|
|
2017
Q2 | $2.33M | Buy |
12,398
+9,798
| +377% | +$1.76M | 0.07% | 166 |
|
|
2017
Q1 | $430K | Sell |
2,600
-2,200
| -46% | -$350K | 0.01% | 767 |
|
|
2016
Q4 | $690K | Buy |
+4,800
| New | +$643K | 0.02% | 547 |
|
|
2016
Q3 | – | Sell |
-15,254
| Closed | -$2M | – | 1503 |
|
|
2016
Q2 | $2M | Buy |
15,254
+12,854
| +536% | +$1.76M | 0.04% | 227 |
|
|
2016
Q1 | $334K | Sell |
2,400
-2,000
| -45% | -$267K | 0.01% | 1226 |
|
|
2015
Q4 | $614K | Sell |
4,400
-9,767
| -69% | -$1.35M | 0.02% | 742 |
|
|
2015
Q3 | $1.98M | Sell |
14,167
-12,190
| -46% | -$1.83M | 0.07% | 190 |
|
|
2015
Q2 | $4.33M | Sell |
26,357
-130,543
| -83% | -$20.9M | 0.13% | 111 |
|
|
2015
Q1 | $24.2M | Buy |
156,900
+135,936
| +648% | +$19.4M | 0.78% | 14 |
|
|
2014
Q4 | $2.63M | Buy |
20,964
+7,034
| +50% | +$869K | 0.09% | 117 |
|
|
2014
Q3 | $1.67M | Buy |
13,930
+3,301
| +31% | +$379K | 0.06% | 153 |
|
|
2014
Q2 | $1.14M | Buy |
10,629
+629
| +6% | +$64.8K | 0.04% | 171 |
|
|
2014
Q1 | $996K | Sell |
10,000
-180,924
| -95% | -$16.4M | 0.04% | 197 |
|
|
2013
Q4 | $17.6M | Buy |
190,924
+181,624
| +1,953% | +$16.1M | 0.86% | 19 |
|
|
2013
Q3 | $778K | Sell |
9,300
-244,800
| -96% | -$21M | 0.03% | 172 |
|
|
2013
Q2 | $20.8M | Buy |
+254,100
| New | +$19M | 1.56% | 10 |
|
Other funds holding ELV
VCM
VPM
Tudor Investment Corp's ELV Position: Q1 2026 in Review
Tudor Investment Corp opened a new position in Elevance Health (ELV) in Q1 2026: 25,499 shares worth $7.46M. The stake represents 0.01% of the portfolio and ranks #921 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in ELV as recently as Q3 2025.
Tudor Investment Corp first reported a position in ELV in Q2 2013 and has held it in 37 quarters since. The position peaked at $25.1M in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Tudor Investment Corp held 25,499 shares of Elevance Health worth $7.46M as of Q1 2026.
- Elevance Health was a new Tudor Investment Corp position in Q1 2026.
- Elevance Health made up 0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #921 holding.
- Tudor Investment Corp first reported a position in Elevance Health in Q2 2013 and has held it in 37 quarters since.
- Tudor Investment Corp's Elevance Health position peaked at $25.1M in Q3 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.